Safety, tolerability, pharmacokinetics, and neutralisation activities of the anti-HIV-1 monoclonal antibody PGT121.414.LS administered alone and in combination with VRC07-523LS in adults without HIV in the USA (HVTN 136/HPTN 092): a first-in-human, open-label, randomised controlled phase 1 trial
Related Posts
Zhao S, McCallum S, Awwad A, Castle PE, Diggs MR, Zanni MV, Chu SM, Lu AB, Currier JS, Aberg JA, Fichtenbaum CJ, Bloomfield GS, Malvestutto[...]
Linde LR, Campbell JI, Horsburgh CR, Fox MP, Abubakar I, Acuna-Villaorduna C, Alikhan F, Andrade BB, Arriaga MB, Balcells ME, Becerra MC, Benjumea-Bedoya D, Bennet[...]
Wiener JM, Hamad CD, Chun RF, Mehany JD, Yeaman MR, Sheppard WL, Bernthal NM. Preoperative Thrombocytopenia and Risk of Periprosthetic Joint Infection After Total Knee[...]